{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:17:01Z","timestamp":1788283021643,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009993","name":"Seattle Children's Center for Clinical and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajo.2026.06.022","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:41:23Z","timestamp":1781883683000},"page":"161-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of the Charlson Comorbidity Index With 1-Year Outcomes in Patients With Macular Edema Secondary to Retinal Vein Occlusion"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2615-9484","authenticated-orcid":false,"given":"JONATHAN J.","family":"XAVIER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAYDEN A.","family":"REED","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KANISHA S.","family":"BAHIERATHAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4827-6906","authenticated-orcid":false,"given":"SONIA B.","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KATHERINE E.","family":"TALCOTT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5859-8162","authenticated-orcid":false,"given":"RISHI P.","family":"SINGH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ajo.2026.06.022_bib0001","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaophthalmol.2014.2854","article-title":"Prevalence of and risk factors for diabetic macular edema in the United States","volume":"132","author":"Varma","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"21","key":"10.1016\/j.ajo.2026.06.022_bib0002","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.3390\/cells11213362","article-title":"Diabetic macular edema: current understanding, molecular mechanisms and therapeutic implications","volume":"11","author":"Zhang","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.022_bib0003","doi-asserted-by":"crossref","first-page":"P288","DOI":"10.1016\/j.ophtha.2019.09.029","article-title":"Retinal vein occlusions preferred practice pattern\u00ae","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.022_bib0004","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.021","article-title":"Ranibizumab for macular edema following central retinal vein occlusion (CRUISE)","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.022_bib0005","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Ranibizumab for macular edema following branch retinal vein occlusion (BRAVO)","volume":"117","author":"Brown","year":"2010","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.022_bib0006","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Dexamethasone implant in macular edema due to retinal vein occlusion (GENEVA)","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2026.06.022_bib0007","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1167\/iovs.08-2231","article-title":"A severity scale for diabetic macular edema developed from ETDRS data","volume":"49","author":"Gangnon","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2026.06.022_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6654168","article-title":"Intravitreal therapy for diabetic macular edema: an update","volume":"2021","author":"Furino","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.06.022_bib0009","series-title":"Kidney Disease Statistics for the United States","year":"2025"},{"key":"10.1016\/j.ajo.2026.06.022_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajo.2020.01.002","article-title":"Visual impairment and major eye diseases in chronic kidney disease","volume":"213","author":"Zhu","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.06.022_bib0011","first-page":"136","article-title":"Retinal vein thrombosis: pathogenesis and risk factors","volume":"29","author":"Rehak","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2026.06.022_bib0012","article-title":"Risk factors for retinal vein occlusion","volume":"2014","author":"Kolar","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ajo.2026.06.022_bib0013","first-page":"1149","article-title":"Inflammation in retinal vein occlusion","volume":"7","author":"Deobhakta","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2026.06.022_bib0014","first-page":"2439","article-title":"Central retinal vein occlusion outcomes in African American patients","volume":"13","author":"Kiew","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.022_bib0018","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"1","key":"10.1016\/j.ajo.2026.06.022_bib0019","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson Comorbidity Index: a critical review","volume":"91","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom"},{"issue":"9","key":"10.1016\/j.ajo.2026.06.022_bib0017","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jamaophthalmol.2020.2974","article-title":"Application of the sight outcomes research collaborative ophthalmology data repository for triaging patients with glaucoma and clinic appointments during pandemics such as COVID-19","volume":"138","author":"Bommakanti","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2026.06.022_bib0020","series-title":"Encyclopedia of Ophthalmology.","first-page":"676","article-title":"Early treatment diabetic retinopathy study (ETDRS)","author":"Leder","year":"2018"},{"issue":"10","key":"10.1016\/j.ajo.2026.06.022_bib0022","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ophtha.2023.05.023","article-title":"SCORE2 Investigator Group. SCORE2 Report 24: nonlinear relationship of retinal thickness and visual acuity in Central retinal and hemiretinal vein occlusion","volume":"130","author":"Scott","year":"2023","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2026.06.022_bib0023","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/IAE.0000000000000851","article-title":"Relationship between retinal thickness and visual acuity in eyes with retinal vein occlusion treated with Dexamethasone implant","volume":"36","author":"Danis","year":"2016","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.ajo.2026.06.022_bib0024","first-page":"1109","article-title":"Loss to follow-up in retina patients receiving anti-VEGF therapy","volume":"136","author":"Obeid","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.06.022_bib0025","first-page":"384","article-title":"Loss to follow-up in retinal vein occlusion patients","volume":"3","author":"Gao","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"10.1016\/j.ajo.2026.06.022_bib0026","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.clinthera.2025.04.010","article-title":"Socioeconomic disparities in intravitreal injection use and anti-VEGF agent selection: aflibercept\/Ranibizumab versus Bevacizumab","volume":"47","author":"Ko","year":"2025","journal-title":"Clin Ther"},{"issue":"7","key":"10.1016\/j.ajo.2026.06.022_bib0027","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.oret.2024.01.017","article-title":"Disparities in retinal vein occlusion presentation and initiation of anti-VEGF therapy: an Academy IRIS\u00ae Registry analysis","volume":"8","author":"Haller","year":"2024","journal-title":"Ophthalmol Retina"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:33:08Z","timestamp":1788280388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426003302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"alternative-id":["S0002939426003302"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.022","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of the Charlson Comorbidity Index With 1-Year Outcomes in Patients With Macular Edema Secondary to Retinal Vein Occlusion","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}